Page 7 - First Wave News Today

​​“I will take out names who have looted and made property wherever. BS Yediyurappa was the Chief Minister in the first wave of corona,” the Vijayapur BJP MLA said.

By Stephen Nakrosis Shares of First Wave BioPharma are lower Thursday, following news the biopharmaceutical company would withdraw a planned offering of...

Peter Brune's Suffering, Redemption and Triumph will have wide appeal, not just to the families and friends of post-war immigrants, but to general readers fascinated by Australia’s military and social history. An overdue addition to the nation's history, this well-produced book is worthy, in the best sense of the word, and often revelatory

By Colin Kellaher Shares of First Wave BioPharma more than doubled in premarket trading Wednesday after the clinical-stage biopharmaceutical company said it...

BOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (“First Wave BioPharma” or the “Company”) (NASDAQ: FWBI), a clinical-stage...

First Wave BioPharma to advance GI development pipeline with the expected addition of Phase 3 Latiglutenase celiac disease program and Phase 2 clinical...

Heading into today, FWBI had slumped 23% in the previous three months and 97% in 2023 First Wave Biopharma (NASDAQ: ) stock is soaring over 140% today. This…

First Wave BioPharma to advance GI development pipeline with the expected addition of Phase 3 Latiglutenase celiac disease program and Phase 2 clinical programs built around Capeserod and AdrulipaseBOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI...

BOCA RATON, Fla., Dec. 27, 2023 -- First Wave BioPharma, Inc. , a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal ...

Phase 3-ready latiglutenase, a targeted oral biotherapeutic for celiac disease, will expand First Wave BioPharma’s late-stage gastrointestinal disease clinical pipeline A concurrent institutional...